PSORIASIS TREATMENTS | ||
---|---|---|
These medications are not recommended for children |
||
Generic | Brand | Adult Dosage |
INTERLEUKIN-12 AND INTERLEUKIN-23 ANTAGONIST1 | ||
ustekinumab | Stelara | 12–17yrs: give SC at Weeks 0 and 4, then every 12wks thereafter. (<60kg): 0.75mg/kg; (60–100kg): 45mg; (>100kg): 90mg. ≥18yrs (≤100kg): initially 45mg SC once, then 4wks later, and then once every 12wks; (>100kg): initially 90mg once, then 4wks later, and then once every 12wks. |
INTERLEUKIN-17A ANTAGONIST | ||
brodalumab | Siliq | 210mg SC at Weeks 0, 1, and 2, then 210mg every 2wks. |
ixekizumab | Taltz | 160mg (given as two 80mg SC injections) at Week 0, then 80mg at Weeks 2, 4, 6, 8, 10, and 12, then 80mg every 4wks. |
secukinumab | Cosentyx | 300mg (given as two 150mg SC injections) at Weeks 0, 1, 2, 3, and 4 then 300mg every 4wks. For some patients, 150mg dose may be acceptable. |
INTERLEUKIN-23 ANTAGONIST | ||
guselkumab | Tremfya | 100mg SC at Weeks 0 and 4, then give every 8wks. |
PSORALEN2 | ||
methoxsalen | 8-MOP | Take Oxsoralen-Ultra 1½–2hrs or 8-MOP 2hrs before UVA exposure with low fat food or milk. (<30kg): 10mg; (30–50kg): 20mg; (51–65kg): 30mg; (66–80kg): 40mg; (81–90kg): 50mg; (91–115kg): 60mg; (>115kg): 70mg. |
Oxsoralen-Ultra | ||
TUMOR NECROSIS FACTOR (TNF) BLOCKERS1 | ||
adalimumab | Humira | Initially 80mg SC, followed by 40mg every other week 1wk after initial dose. |
certolizumab pegol | Cimzia | 400mg (two 200mg inj at separate sites) SC every other week. ≤90kg: may consider 400mg on Day 1, then at Weeks 2 and 4, followed by 200mg every other week. |
etanercept | Enbrel | Initially 50mg SC twice weekly for 3mos (also: initial doses of 25mg or 50mg per week were shown to be efficacious). Maintenance: 50mg once weekly. |
infliximab | Remicade | 5mg/kg IV infusion at Weeks 0, 2 and 6; then give every 8wks. |
OTHERS | ||
acitretin | Soriatane | 25–50mg once daily with main meal; may discontinue when lesions resolve. May repeat if relapse occurs. |
apremilast | Otezla | Starting on Day 1: 10mg in the AM. Day 2: 10mg in AM and 10mg in PM. Day 3: 10mg in AM and 20mg in PM. Day 4: 20mg in AM and 20mg in PM. Day 5: 20mg in AM and 30mg in PM. Following on Day 6 and thereafter: 30mg twice daily (AM & PM). |
betamethasone dipropionate | Sernivo | Apply twice daily for up to max 4wks; discontinue when control is achieved. |
calcipotriene + betamethasone dipropionate | Enstilar | Apply once daily for up to 4wks; discontinue when control is achieved; max 60g every 4 days. |
clobetasol propionate | Impoyz | Apply twice daily; discontinue when control is achieved; max 50g/week and 2 consecutive weeks’ treatment per course. |
cyclosporine | Gengraf3 | 1.25mg/kg twice daily; may increase after 4wks by 0.5mg/kg/day, then adjust at 2-week intervals; max 4mg/kg/day. |
Neoral3 | 1.25mg/kg twice daily; may increase after 4wks by 0.5mg/kg/day, then adjust at 2-week intervals; max 4mg/kg/day. | |
methotrexate | Otrexup | 10-25mg once weekly using an oral, IM, SC, or IV form; max 30mg/wk. Use alternative MTX form in patients requiring oral, IM, IV, intra-arterial, or intrathecal dosing, doses <7.5mg/week or >30mg/week, high-dose regimens, or dose adjustments <2.5mg increments. |
Rasuvo | ||
NOTES | ||
1 These medications should only be used under the guidance and supervision of a physician. 2 Intended to be administered only in conjunction with a schedule of controlled doses of long wave UV radiation. See full labeling for UVA exposure schedule. 3 Not bioequivalent to all other forms of cyclosporine; do not interchange without physician supervision. Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling. (Rev. 8/2018) |